Seguir
Flavio A Cadegiani
Flavio A Cadegiani
Corpometria Institute; Applied Biology
E-mail confirmado em unifesp.br
Título
Citado por
Citado por
Ano
Hormonal aspects of overtraining syndrome: a systematic review
FA Cadegiani, CE Kater
BMC Sports Science, Medicine and Rehabilitation 9 (1), 1-15, 2017
1272017
Hypothalamic-pituitary-adrenal (HPA) axis functioning in overtraining syndrome: findings from endocrine and metabolic responses on overtraining syndrome (EROS)—EROS-HPA Axis
FA Cadegiani, CE Kater
Sports medicine-open 3 (1), 1-11, 2017
622017
Body composition, metabolism, sleep, psychological and eating patterns of overtraining syndrome: results of the EROS study (EROS-PROFILE)
FA Cadegiani, CE Kater
Journal of sports sciences 36 (16), 1902-1910, 2018
602018
Adrenal fatigue does not exist: a systematic review
FA Cadegiani, CE Kater
BMC endocrine disorders 16 (1), 1-16, 2016
512016
Novel insights of overtraining syndrome discovered from the EROS study
FA Cadegiani, CE Kater
BMJ Open Sport & Exercise Medicine 5 (1), e000542, 2019
482019
Basal hormones and biochemical markers as predictors of overtraining syndrome in male athletes: the EROS-BASAL study
FA Cadegiani, CE Kater
Journal of athletic training 54 (8), 906-914, 2019
472019
Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double …
FA Cadegiani, J McCoy, CG Wambier, S Vaño-Galván, J Shapiro, A Tosti, ...
Cureus 13 (2), 2021
442021
Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and Time-to-Remission in males with COVID-19: a randomized, double-blind, placebo …
FA Cadegiani, J McCoy, CG Wambier, A Goren
Cureus 13 (2), 2021
442021
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.
A Goren, CG Wambier, S Herrera, J McCoy, S Vaño-Galván, F Gioia, ...
Wiley, 2021
442021
Novel causes and consequences of overtraining syndrome: the EROS-DISRUPTORS study
FA Cadegiani, CE Kater
BMC Sports Science, Medicine and Rehabilitation 11 (1), 1-13, 2019
402019
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia.
J McCoy, FA Cadegiani, CG Wambier, S Herrera, S Vaño-Galván, ...
Wiley, 2021
392021
Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)
FA Cadegiani, A Goren, CG Wambier
Medical Hypotheses 143, 110112, 2020
392020
Repurposing existing drugs for COVID-19: an endocrinology perspective
FA Cadegiani
BMC Endocrine Disorders 20 (1), 1-19, 2020
372020
Clinical and biochemical characteristics of high-intensity functional training (HIFT) and overtraining syndrome: findings from the EROS study (The EROS-HIFT)
FA Cadegiani, CE Kater, M Gazola
Journal of sports sciences 37 (11), 1296-1307, 2019
362019
Hormonal response to a non-exercise stress test in athletes with overtraining syndrome: results from the endocrine and metabolic responses on Overtraining syndrome (EROS)—EROS …
FA Cadegiani, CE Kater
Journal of Science and Medicine in Sport 21 (7), 648-653, 2018
352018
Clinical symptoms of hyperandrogenic women diagnosed with COVID-19
FA Cadegiani, RK Lim, A Goren, J McCoy, M Situm, M Kovacevic, ...
WILEY, 2020
332020
Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
FA Cadegiani
American Journal of Physiology-Endocrinology and Metabolism 318 (5), E587-E588, 2020
332020
Spironolactone: an anti-androgenic and anti-hypertensive drug that may provide protection against the novel coronavirus (SARS-CoV-2) induced acute respiratory distress syndrome …
FA Cadegiani, CG Wambier, A Goren
Frontiers in medicine 7, 453, 2020
322020
Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients.
J McCoy, CG Wambier, S Herrera, S Vaño-Galván, F Gioia, B Comeche, ...
Journal of the European Academy of Dermatology and Venereology: JEADV 35 (1 …, 2021
302021
Proxalutamide reduces the rate of hospitalization for COVID-19 male outpatients: a randomized double-blinded placebo-controlled trial
J McCoy, A Goren, FA Cadegiani, S Vaño-Galván, M Kovacevic, M Situm, ...
Frontiers in medicine, 1043, 2021
29*2021
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20